Last week, the members of the SIF had the pleasure of hosting Union trustee Tom Coleman (class of 1988). Mr. Coleman captivated his audience with stories of a street-style basketball shoe brand that he founded in the early 1990s; his part-time job at a hedge fund while attending Columbia Business School; and his experience of…
Read More
What is BYD? BYD stands for “Build Your Dreams”. It is a Chinese manufacturer of electric and hybrid vehicles with sales in Asia, Latin America and Europe. It was founded by Wang Chuanfu in 1995 in Shenzhen, China where it is headquartered. BYD started as a battery-making company but transitioned into the electric vehicle market…
Read More
What is Prologis? According to its 2023 annual report, “Prologis is the global leader in logistics real estate with a focus on high-barrier, high-growth markets.” The logistics real estate sector provides warehouse distribution and fulfillment centers to streamline supply chains and meet the demands of both traditional and online commerce. Prologis develops and manages these…
Read More
On April 3rd, the Student Investment Fund had the honor to host David A Katz (Union Class of ‘84), President and Chief Investment Officer of Matrix Asset Advisor, a firm David co-founded in 1986. David has an MBA from NYU, is a CFA charter holder, and appears frequently as a guest on CNBC (e.g. here…
Read More
The SIF currently owns 75 shares of Facebook (FB) and it makes up 2% of the portfolio. Although the company has grown its profitability and has a relatively low beta of .62 over the past 3 months, the ongoing concerns over data collection, privacy issues, personnel conflicts, and Russian interference pose sufficient risk to warrant selling out…
Read More
Gilead Pharmaceuticals, a biopharmaceutical company, discovers, develops and commercializes therapeutics in the areas of unmet medical needs in the United States, Europe, and internationally. Gilead pharmaceuticals is an attractive investment for three main reasons. First, it is incredibly undervalued compared to its competition. Gilead’s EV/EBITDA ratio is 8.18 currently compared to an industry average of…
Read More